Nifty Healthcare Index's PB is more expensive than 72% of the last 5 years.
The Nifty Healthcare Index PE ratio is 46.83 as of 19 November 2026, about 24% above its 5-year median of 37.62, which places it in moderately overvalued territory on a historical basis.
| Period | Median PE | Current vs Median |
|---|---|---|
| 5 Years | 37.62 | +24.48% |
| 3 Years | 39.73 | +17.87% |
| 1 Year | 39.98 | +17.15% |
Series start. P/E is published from 18 Nov 2020. Index values go back to 1 Apr 2005.
Index earnings are the profits behind the index level: the closing value divided by the P/E ratio, in index points. The line moves in steps because it changes only when trailing four-quarter profits are updated or the constituents change. Compare it with price to see whether a move came from earnings or from a change in what investors pay for them.
Nifty Healthcare Index earnings grew +7.46% a year over the last 5 years, while the index moved +14.88% a year and its P/E went from 33.5 to 46.8.
Earnings growth is annualised from the last trading day at or before the start of each window to 19 Nov 2026. Price growth uses the index level over the same two dates, excluding dividends. EPS is undefined on days with no published P/E, so those days are skipped. Past growth, not a forecast.
4 ETFs and 1 index fund track this index. Prices and NAVs as of 18 Nov 2026.
| ETF | Symbol | Price | NAV | Premium | 1Y |
|---|---|---|---|---|---|
| ICICI Prudential Nifty Healthcare ETF | HEALTHIETF | 177.19 | - | - | +16.99% |
| Aditya Birla Sun Life Nifty Healthcare ETF | HEALTHY | 17.7 | - | - | +16.81% |
| Axis NIFTY Healthcare ETF | HEALTHAXIS | 177 | - | - | - |
| DSP Nifty Healthcare ETF | HEALTHADD | 17.54 | - | - | - |
| Fund | AMC | NAV | Since |
|---|---|---|---|
| DSP Nifty Healthcare Index Fund | DSP Asset Managers Private Limited | 12.2718 Nov 2026 | 2025 |
Listed for information only, not a recommendation. Check expense ratio and tracking difference before investing.
The Nifty Healthcare Index contains 20 constituents.
4 October 2026: Added Gland Pharma Ltd., Krishna Institute of Medical Sciences Ltd.. Removed Piramal Pharma Ltd., Syngene International Ltd..
Constituent list as of 15 November 2026, sourced from NSE Indices.
Get weekly market insights and valuation updates delivered to your inbox.
As of 19 November 2026, the Nifty Healthcare Index PE ratio is 46.83. That is about 24% above its 5-year median of 37.62 and about 17% above its 1-year median of 39.98.
On a historical basis it screens as moderately overvalued. Its current PE of 46.83 sits above every median window: 1-year (39.98), 3-year (39.73) and 5-year (37.62).
Over the past five years its median PE has been 37.62, and over the past three years 39.73. Today's 46.83 is toward the upper end of that historical range.
The Nifty Healthcare Index contains 20 stocks. By number of companies, its largest sectors are Healthcare (20 stocks).
Nifty Healthcare Index earnings, measured as the index level divided by its P/E, grew +7.46% a year over the last 5 years, while the index itself moved +14.88% a year and its P/E rose from 33.54 to 46.83. Past growth, not a forecast.
Last updated: 19 November 2026.